Antibody-Mediated Coengagement of FcγRIIb and B Cell Receptor Complex Suppresses Humoral Immunity in Systemic Lupus ErythematosusHolly M. Horton, David E. Szymkowski, Seung Y. Chu et al.|The Journal of Immunology|2011Cited by 144
The impact of Fc engineering on an anti-CD19 antibody: increased Fcγ receptor affinity enhances B-cell clearing in nonhuman primatesJonathan Zalevsky, Chris E. Lawrence, Irene Leung et al.|Blood|2008Cited by 101
XmAb™2513, an Fc Engineered Humanized Anti-CD30 Monoclonal Antibody, Has Potent In Vitro and In Vivo Activities, and Has the Potential for Treating Hematologic Malignancies.Chris E. Lawrence, David F. Carmichael, Phil W. Hammond et al.|Blood|2007Cited by 11
XmAb®5574, An Fc Engineered Humanized Anti-CD19 Monoclonal Antibody, Has Potent in Vitro and in Vivo Activities, and Has the Potential for Treating B Cell MalignanciesChris E. Lawrence, David F. Carmichael, Jonathan Zalevsky et al.|Blood|2008Cited by 1
Inhibition of B Cell Receptor-Mediated B Cell Activation and IgE secretion by Coengagement of Surface IgE and FcγRIIb with Fc-Engineered AntibodiesDavid E. Szymkowski, John R. Desjarlais, Seung Y. Chu et al.|Journal of Allergy and Clinical Immunology|2010Cited by 0